NasdaqCM - Nasdaq Real Time Price USD
Brainstorm Cell Therapeutics Inc. (BCLI)
0.8896
+0.0205
+(2.36%)
As of 12:16:13 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,093
-9,093
-19,320
-26,265
-35,193
Investing Cash Flow
12
12
998
323
-4,452
Financing Cash Flow
7,967
7,967
238
6,969
76,938
End Cash Position
371
371
772
18,856
37,829
Capital Expenditure
-18
--
-29
-330
-378
Issuance of Capital Stock
7,967
7,967
238
6,964
60,729
Repurchase of Capital Stock
--
--
--
--
-116
Free Cash Flow
-9,093
-9,093
-19,349
-26,595
-35,571
12/31/2020 - 10/7/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLRX BioLineRx Ltd.
3.0737
+2.46%
PLUR Pluri Inc.
6.14
-9.08%
SVRA Savara Inc.
3.2650
+0.46%
VYGR Voyager Therapeutics, Inc.
3.5200
+0.86%
CERO CERo Therapeutics Holdings, Inc.
1.0750
+34.26%
MTVA MetaVia Inc.
0.8277
+1.81%
GUTS Fractyl Health, Inc.
1.3550
+1.88%
VRPX Virpax Pharmaceuticals, Inc.
0.2600
0.00%
PPBT Purple Biotech Ltd
2.7067
+0.25%
ENLV.TA Enlivex Therapeutics Ltd.
337.50
+2.09%